YI
111, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- S May 26 to May 27 2 days of insider sells: $132.5K by 3 insiders, avg $0.2559
- S Jun 9 to Jun 15 5 days of insider sells: $213.9K by 2 insiders, avg $0.2263
- E Sep 17 M&A: 111 Inc. Receives Unsolicited Preliminary Non-Binding Prop…
- R Sep 17 The co-founders of 111, Inc. (Dr. Gang Yu and Mr. Junling Liu) toget…
- R Sep 17 111, Inc. reported Q2 2026 unaudited results showing a 28.3% YoY rev…
- S Sep 23 to Sep 28 2 days of insider sells: $22.7K by 1 insider, avg $0.1800
- R Sep 28 111, Inc. announced the formation of a Special Committee of independ…
- X Sep 30 Short interest falls 34.7% to 7.0K
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders sold $369.1K.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 0 trimmed or exited.
- TrendDOWNTREND
10% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $6.9K |
| UBS Group AG | TRIM | $652.00 |
| UBS Group AG | NEAR_EXIT | $776.00 |
| MORGAN STANLEY | NEAR_EXIT | $358.00 |
| JPMORGAN CHASE & CO | ADD | $107.00 |
| UBS Group AG | NEAR_EXIT | $6.6K |
| JPMORGAN CHASE & CO | DOUBLED | $108.00 |
| UBS Group AG | DOUBLED | $43.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 28, 2026 | Chen Yang Luke Director | SELL | $6.9K |
| Sep 23, 2026 | Chen Yang Luke Director | SELL | $7.9K |
| Sep 23, 2026 | Chen Yang Luke Director | SELL | $7.9K |
| Jun 15, 2026 | Chen Yang Luke Director | SELL | $10.1K |
| Jun 15, 2026 | Chen Yang Luke Director | SELL | $10.1K |
| Jun 15, 2026 | Sun Jian David Director | SELL | $13.5K |
| Jun 15, 2026 | Chen Yang Luke Director | SELL | $10.1K |
| Jun 12, 2026 | Chen Yang Luke Director | SELL | $11.5K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Sep 10, 2026 | Volatility Pause | Resumed |
| Sep 8, 2026 | Volatility Pause | Resumed |
| Aug 31, 2026 | Volatility Pause | Resumed |
SecBot reports
11 filings · 1 press release · 3 bullish · 4 bearish · 1 mixed · 3 neutral- NEUTRAL 6-KOct 26, 2026
111, Inc. announced that the Special Committee of independent directors has retained Houlihan…
The appointment of reputable advisors signals the Special Committee is actively advancing the review process. Watch for a definitive agreement or competing bids; the consortium's super-voting…
- BULLISH 6-KSep 28, 2026
111, Inc. announced the formation of a Special Committee of independent directors to evaluate a…
The establishment of a Special Committee is a procedural step that increases the probability of a formal go-private process, but the lack of a price or definitive terms leaves significant…
- BULLISH SC 13DSep 17, 2026
The co-founders of 111, Inc. (Dr. Gang Yu and Mr. Junling Liu) together with Huadeng Tech BioArray…
Watch for the formation of the special committee and the negotiation of a definitive merger agreement. The co-founders' super-voting control (~91.3% voting power) makes competing bids unlikely, but…
- BEARISH 6-KSep 17, 2026
111, Inc. reported Q2 2026 unaudited results showing a 28.3% YoY revenue decline to RMB2.3 billion…
The revenue decline is structural due to the asset-light pivot, but the widening net loss and cash burn are concerning. Watch for further updates on the 1 Pharmacy Technology redemption…
All YI filing & press-release reports (12)
- 6-K reportOct 26, 2026
- 6-K reportSep 28, 2026
- SC 13D reportSep 17, 2026
- 6-K reportSep 17, 2026
- 6-K reportSep 17, 2026
- PRESS-RELEASE reportSep 17, 2026
- CLUSTER reportJun 16, 2026
- CLUSTER reportJun 12, 2026
- 6-K reportJun 4, 2026
- CLUSTER reportMay 29, 2026
- 20-F reportApr 30, 2026
- 6-K reportApr 9, 2026